Subscribe To
Greenwich lifesciences reveals 5-year data for gp2 immunotherapy in breast cancer settings
Greenwich LifeSciences Inc (NASDAQ: GLSI) has published new GP2 Phase 2b trial data. The trial enrolled HER2 positive patients, who received a ...
December 9, 2021, 1:19 pm
Greenwich lifesciences reveals 5-year data for gp2 immunotherapy in breast cancer settings
Greenwich LifeSciences Inc (NASDAQ: GLSI) has published new GP2 Phase 2b trial data. The trial enrolled HER2 positive patients, who received a ...
December 9, 2021, 1:19 pm
Greenwich lifesciences reveals 5-year data for gp2 immunotherapy in breast cancer settings
Greenwich LifeSciences Inc (NASDAQ: GLSI) has published new GP2 Phase 2b trial data. The trial enrolled HER2 positive patients, who received a ...
December 9, 2021, 1:19 pm
New body is trying to fix the 'alphabet soup' of sustainable finance standards: sfc ceo
Ashley Alder, CEO of the Securities and Futures Commission says the newly announced International Sustainability Standards Board will help create glob...
November 30, 2021, 12:14 am
New body is trying to fix the 'alphabet soup' of sustainable finance standards: sfc ceo
Ashley Alder, CEO of the Securities and Futures Commission says the newly announced International Sustainability Standards Board will help create glob...
November 30, 2021, 12:14 am
New body is trying to fix the 'alphabet soup' of sustainable finance standards: sfc ceo
Ashley Alder, CEO of the Securities and Futures Commission says the newly announced International Sustainability Standards Board will help create glob...
November 30, 2021, 12:14 am
Electrovaya: contender to ev battery market
Addressable market for E-mobility is immense and rapidly growing. EFLVF has developed innovative lithium-ion cells with solid-state coatings, which ha...
November 28, 2021, 4:34 pm
Electrovaya: contender to ev battery market
Addressable market for E-mobility is immense and rapidly growing. EFLVF has developed innovative lithium-ion cells with solid-state coatings, which ha...
November 28, 2021, 4:34 pm
Electrovaya: contender to ev battery market
Addressable market for E-mobility is immense and rapidly growing. EFLVF has developed innovative lithium-ion cells with solid-state coatings, which ha...
November 28, 2021, 4:34 pm
Why camber energy shares are rising
Camber Energy, Inc. (NYSE: CEI) shares are trading higher after the company announced it received a letter from the NYSE American in response to the c...
November 22, 2021, 1:32 pm
Why camber energy shares are rising
Camber Energy, Inc. (NYSE: CEI) shares are trading higher after the company announced it received a letter from the NYSE American in response to the c...
November 22, 2021, 1:32 pm
Why camber energy shares are rising
Camber Energy, Inc. (NYSE: CEI) shares are trading higher after the company announced it received a letter from the NYSE American in response to the c...
November 22, 2021, 1:32 pm
Is confluent a buy?
You should take a look at this gold-standard real-time data company....
November 20, 2021, 7:55 am
Is confluent a buy?
You should take a look at this gold-standard real-time data company....
November 20, 2021, 7:55 am
Is confluent a buy?
You should take a look at this gold-standard real-time data company....
November 20, 2021, 7:55 am
Lendingclub backs us truth in lending bill to extend transparency
LendingClub is backing the Small Business Lending Disclosure Act, a bill introduced in the U.S. House and Senate this week that calls for extending th...
November 19, 2021, 1:51 pm
Lendingclub backs us truth in lending bill to extend transparency
LendingClub is backing the Small Business Lending Disclosure Act, a bill introduced in the U.S. House and Senate this week that calls for extending th...
November 19, 2021, 1:51 pm
Lendingclub backs us truth in lending bill to extend transparency
LendingClub is backing the Small Business Lending Disclosure Act, a bill introduced in the U.S. House and Senate this week that calls for extending th...
November 19, 2021, 1:51 pm
Imugene's current success sees analyst raise price target
Imugene Limited (ASX:IMU, OTC:IUGNF) is buoyed by a new research report from Roth Capital Partners after signing a clinical trial supply agreement w...
November 18, 2021, 10:28 pm
Imugene's current success sees analyst raise price target
Imugene Limited (ASX:IMU, OTC:IUGNF) is buoyed by a new research report from Roth Capital Partners after signing a clinical trial supply agreement w...
November 18, 2021, 10:28 pm